Insider Transactions

Date Name Title Type Shares Traded Price Range
Nov 21, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 14,000 $13.53
Nov 21, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 14,000 --
Nov 15, 2017 SVP, GM - Oncology Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 --
Nov 15, 2017 SVP, GM - Oncology Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 17,409 $11.92
Nov 15, 2017 SVP, GM - Oncology Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 $10.63
Nov 15, 2017 SVP, GM - Oncology Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 17,409 --
Nov 15, 2017 SVP, GM - Oncology Open market or private sale of non-derivative or derivative security 27,409 $16.29
Sep 12, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 14,000 $13.53
Sep 12, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 14,000 --
Sep 12, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 25,000 --
 For recent transactions, including derivative transactions, see our Section 16 SEC filings page.